Literature DB >> 28351573

Head and neck lymphomas: A 20-year review in an Oral Pathology Unit, Johannesburg, South Africa, a country with the highest global incidence of HIV/AIDS.

Nasreen Alli1, Shabnum Meer2.   

Abstract

OBJECTIVES: Non-Hodgkin lymphoma occurs with increasing frequency in HIV/AIDS. As South Africa has the highest incidence of HIV/AIDS worldwide, an epidemiologic study of this nature provides insight into head and neck lymphomas in a defined South African population. This retrospective review evaluated frequency and clinico-pathologic characteristics of patients diagnosed with head and neck lymphoma at the Oral Pathology Department, University of Witwatersrand between 1993 and 2012.
MATERIALS AND METHODS: Histopathology reports of patients with head and neck lymphomas (n=504) were reviewed. Demographic (age, gender), clinical (site and size of tumour), laboratory and histological parameters were recorded.
RESULTS: There were 504 patients with head and neck lymphomas. The mean age was 40.4years. The male:female ratio was 1.1:1. The cervical lymph node was the most common anatomic site (115 cases) and the maxilla (60 cases) the most common extranodal site. Plasmablastic lymphoma (159 cases) was the most common histologic subtype, seen more frequently as a result of its strong association with HIV/AIDS. The most common Hodgkin's lymphoma was the nodular sclerosing variant (21 cases). Of the head and neck lymphomas in patients with a known HIV status, 56% had plasmablastic lymphoma, 43.9% diffuse large B cell lymphoma and 25% Burkitt lymphoma.
CONCLUSION: There is an increase in head and neck lymphoma frequency, contrary to that found in Western countries. The high HIV prevalence in certain lymphomas provides strong indication of the role of HIV/AIDS in pathogenesis of lymphomas. This study serves as a baseline for future studies, especially in South Africa.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; HIV; Head and neck lymphomas; Plasmablastic lymphoma

Mesh:

Year:  2017        PMID: 28351573     DOI: 10.1016/j.oraloncology.2017.01.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

1.  Oral lesion as the primary diagnosis of non-Hodgkin's lymphoma: a 20-year experience from an oral pathology service and review of the literature.

Authors:  Natália Kusuke; Marcos Custódio; Suzana C O M de Sousa
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-08       Impact factor: 2.503

2.  Lymphomas Affecting the Sublingual Glands: A Clinicopathological Study.

Authors:  Gabriela Ribeiro de Araújo; Ana Luísa Morais-Perdigão; Cinthia Verónica Bardález Lopez de Cáceres; Márcio Ajudarte Lopes; José Manuel Aguirre-Urizar; Roman Carlos; Elena María José Román Tager; Willie F P van Heerden; Liam Robinson; Hélder Antônio Rebelo Pontes; Bruno Augusto Benevenuto de Andrade; Ciro Dantas Soares; Ricardo Santiago Gomez; Felipe Paiva Fonseca
Journal:  Head Neck Pathol       Date:  2022-09-27

3.  Primary Epithelial Minor Salivary Gland Tumors in South Africa: A 20-Year Review.

Authors:  Yaseer Mahomed; Shabnum Meer
Journal:  Head Neck Pathol       Date:  2019-12-23

Review 4.  Maxillofacial lymphomas.

Authors:  David MacDonald; Montgomery Martin; Kerry Savage
Journal:  Br J Radiol       Date:  2021-01-06       Impact factor: 3.039

5.  Localized gingival enlargements. A clinicopathological study of 1187 cases.

Authors:  P Tamiolakis; E Chatzopoulou; F Frakouli; K-I Tosios; A Sklavounou-Andrikopoulou
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-05-01

6.  HIV-related non-Hodgkin lymphomas affecting the oral cavity: a clinicopathologic study of 11 cases.

Authors:  D-C Uchôa; F-S Pontes; L-L Souza; G-S Santos; A-C Prado-Ribeiro; T-B Brandão; L-R Oliveira; C-C Gomes; A-R Santos-Silva; F-P Fonseca; O-P Almeida; H-A Pontes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01

7.  Oral Malignant Non-Hodgkin Lymphoma: A Retrospective Single-Center Study.

Authors:  Selene Barone; Caterina Buffone; Martina Ferrillo; Federica Pasqua; Stefano Parrotta; Marianna Salviati; Francesco Bennardo; Alessandro Antonelli
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.